COMMUNIQUÉS West-GlobeNewswire
-
Cannabix Technologies Enters into Marketing Agreements
14/05/2024 - 00:30 -
HUTCHMED Initiates the RAPHAEL Registrational Phase III Trial of HMPL-306 for Patients with IDH1- and/or IDH2-Mutated Relapsed/Refractory Acute Myeloid Leukemia in China
14/05/2024 - 02:00 -
HUTCHMED Initiates Phase II/III Trial of the Combination of Surufatinib and Camrelizumab for Treatment-Naïve Pancreatic Ductal Adenocarcinoma in Collaboration with Hengrui
14/05/2024 - 02:00 -
Pacific Health Care Organization, Inc. Reports its First Quarter 2024 Results
14/05/2024 - 02:22 -
Aurora Spine Corporation Announces First Quarter 2024 Financial Results
14/05/2024 - 03:09 -
Acumen Pharmaceuticals to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
13/05/2024 - 22:00 -
Akoya Biosciences Reports First Quarter 2024 Financial Results
13/05/2024 - 22:00 -
AVITA Medical Reports First Quarter Financial Results
13/05/2024 - 22:01 -
Allogene Therapeutics Reports First Quarter 2024 Financial Results and Business Update
13/05/2024 - 22:01 -
Assure & Danam to Host Corporate Update Call & Webcast
13/05/2024 - 22:01 -
Teknova Reports First Quarter 2024 Financial Results
13/05/2024 - 22:01 -
Vaxart Provides Business Update and Reports First Quarter 2024 Financial Results
13/05/2024 - 22:01 -
Invivyd to Participate at the H.C. Wainwright 2nd Annual BioConnect Investor Conference
13/05/2024 - 22:01 -
Aprea Therapeutics to Attend the 2024 RBC Capital Markets Global Healthcare Conference
13/05/2024 - 22:01 -
Cara Therapeutics Reports First Quarter 2024 Financial Results
13/05/2024 - 22:01 -
Voyager Therapeutics Reports First Quarter 2024 Financial and Operating Results
13/05/2024 - 22:01 -
Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
13/05/2024 - 22:01 -
Stereotaxis Announces Definitive Agreement to Acquire Access Point Technologies
13/05/2024 - 22:02 -
Augmedix Delivers 40% Revenue Growth for First Quarter of 2024
13/05/2024 - 22:03
Pages